Paraneoplastic neurological syndromes (PNS) are remote effects of cancer and often are associated with high concentrations of so-called well-characterized onconeural antibodies (anti-Hu, Yo, Ri, CV2/CRMP5, Ma1, Ma2, and amphiphysin) that help to establish the diagnosis [6]. Here, DPYSL5 is linked to cancer.